Summary of Study ST000802

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000576. The data can be accessed directly via it's Project DOI: 10.21228/M86X1F This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)
Study IDST000802
Study TitleInsights into myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) phenotypes through comprehensive metabolomics (part III))
Study TypeObservational
Study SummaryThe pathogenesis of ME/CFS, a disease characterized by unexplained debilitating fatigue, cognitive dysfunction, sleep disturbances, orthostatic intolerance, fever, lymphadenopathy and irritable bowel syndrome (IBS), is poorly understood. There are no validated diagnostic tests or interventions to mitigate disease. Here we report association modeling, biomarker discovery, biochemical enrichment analysis and topological network visualization of plasma metabolomic, fecal bacterial metagenomic and clinical data from 50 ME/CFS patients and 50 healthy controls. Through targeted and untargeted metabolomics analyses we confirm earlier reports of specific alterations in plasma levels of choline, carnitine and complex lipid metabolism in ME/CFS. We also demonstrate that patients with ME/CFS and IBS have a unique metabolomic profile that includes increased plasma levels of ceramide, a waxy lipid implicated in suppression of electron transport, insulin and leptin resistance and apoptosis. Integration of fecal metagenomic and plasma metabolomic data resulted in a stronger predictive model of ME/CFS (cross-validated AUC=0.836) than either metagenomic (cross-validated AUC=0.745) or metabolomic (cross-validated AUC=0.820) analysis alone. Our findings may provide insights into the pathogenesis of ME/CFS and ME/CFS subtypes, and suggest pathways for the development of diagnostic and therapeutic strategies.
Institute
University of California, Davis
DepartmentGenome and Biomedical Sciences Facility
LaboratoryWCMC Metabolomics Core
Last NameFiehn
First NameOliver
Address1315 Genome and Biomedical Sciences Facility, 451 Health Sciences Drive, Davis, CA 95616
Emailofiehn@ucdavis.edu
Phone(530) 754-8258
Submit Date2017-07-19
Study CommentsKey: MECFS: 1 in this column indicates case, while 0 indicates control IBS: 1 in this column indicates the patient does have disease, 0 indicates free of IBS
PublicationsInsights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics. Scientific Reports volume 8, Article number: 10056 (2018). Dorottya Nagy-Szakal, Dinesh K. Barupal, Bohyun Lee, Xiaoyu Che, Brent L. Williams, Ellie J. R. Kahn, Joy E. Ukaigwe, Lucinda Bateman, Nancy G. Klimas, Anthony L. Komaroff, Susan Levine, Jose G. Montoya, Daniel L. Peterson, Bruce Levin, Mady Hornig, Oliver Fiehn & W. Ian Lipkin.
Raw Data AvailableYes
Raw Data File Type(s)wiff
Analysis Type DetailLC-MS
Release Date2018-08-16
Release Version1
Oliver Fiehn Oliver Fiehn
https://dx.doi.org/10.21228/M86X1F
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR000576
Project DOI:doi: 10.21228/M86X1F
Project Title:Insights into myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) phenotypes through comprehensive metabolomics
Project Summary:The pathogenesis of ME/CFS, a disease characterized by unexplained debilitating fatigue, cognitive dysfunction, sleep disturbances, orthostatic intolerance, fever, lymphadenopathy and irritable bowel syndrome (IBS), is poorly understood. There are no validated diagnostic tests or interventions to mitigate disease. Here we report association modeling, biomarker discovery, biochemical enrichment analysis and topological network visualization of plasma metabolomic, fecal bacterial metagenomic and clinical data from 50 ME/CFS patients and 50 healthy controls.
Institute:Columbia University
Department:Center for Infection and Immunity, Mailman School of Public Health
Last Name:Lipkin
First Name:Ian
Address:722 West 168th Street, Room 1703a, New York, NY USA 10032
Email:wil2001@columbia.edu
Phone:212-342-9044
Publications:Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics. Scientific Reports volume 8, Article number: 10056 (2018). Dorottya Nagy-Szakal, Dinesh K. Barupal, Bohyun Lee, Xiaoyu Che, Brent L. Williams, Ellie J. R. Kahn, Joy E. Ukaigwe, Lucinda Bateman, Nancy G. Klimas, Anthony L. Komaroff, Susan Levine, Jose G. Montoya, Daniel L. Peterson, Bruce Levin, Mady Hornig, Oliver Fiehn & W. Ian Lipkin.

Subject:

Subject ID:SU000827
Subject Type:Human
Subject Species:Homo sapiens
Taxonomy ID:9606
Species Group:Human

Factors:

Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)

mb_sample_id local_sample_id CaseStatus
SA044110ESP-0891Case | SEX:Female | AGE_DICH:20_50
SA044111ESP-0189Case | SEX:Female | AGE_DICH:20_50
SA044112ESP-0345Case | SEX:Female | AGE_DICH:20_50
SA044113ESP-0332Case | SEX:Female | AGE_DICH:20_50
SA044114ESP-0228Case | SEX:Female | AGE_DICH:20_50
SA044115ESP-0280Case | SEX:Female | AGE_DICH:20_50
SA044116ESP-0865Case | SEX:Female | AGE_DICH:20_50
SA044117ESP-0683Case | SEX:Female | AGE_DICH:20_50
SA044118ESP-0137Case | SEX:Female | AGE_DICH:20_50
SA044119ESP-0566Case | SEX:Female | AGE_DICH:20_50
SA044120ESP-0514Case | SEX:Female | AGE_DICH:20_50
SA044121ESP-0501Case | SEX:Female | AGE_DICH:20_50
SA044122ESP-0592Case | SEX:Female | AGE_DICH:20_50
SA044123ESP-1047Case | SEX:Female | AGE_DICH:20_50
SA044124ESP-0995Case | SEX:Female | AGE_DICH:20_50
SA044125ESP-0124Case | SEX:Female | AGE_DICH:20_50
SA044126ESP-0605Case | SEX:Female | AGE_DICH:20_50
SA044127ESP-0007Case | SEX:Female | AGE_DICH:over50
SA044128ESP-0709Case | SEX:Female | AGE_DICH:over50
SA044129ESP-0696Case | SEX:Female | AGE_DICH:over50
SA044130ESP-0748Case | SEX:Female | AGE_DICH:over50
SA044131ESP-0878Case | SEX:Female | AGE_DICH:over50
SA044132ESP-1125Case | SEX:Female | AGE_DICH:over50
SA044133ESP-1138Case | SEX:Female | AGE_DICH:over50
SA044134ESP-1151Case | SEX:Female | AGE_DICH:over50
SA044135ESP-1164Case | SEX:Female | AGE_DICH:over50
SA044136ESP-1034Case | SEX:Female | AGE_DICH:over50
SA044137ESP-0982Case | SEX:Female | AGE_DICH:over50
SA044138ESP-0800Case | SEX:Female | AGE_DICH:over50
SA044139ESP-0488Case | SEX:Female | AGE_DICH:over50
SA044140ESP-0943Case | SEX:Female | AGE_DICH:over50
SA044141ESP-0956Case | SEX:Female | AGE_DICH:over50
SA044142ESP-0761Case | SEX:Female | AGE_DICH:over50
SA044143ESP-0657Case | SEX:Female | AGE_DICH:over50
SA044144ESP-0241Case | SEX:Female | AGE_DICH:over50
SA044145ESP-0085Case | SEX:Female | AGE_DICH:over50
SA044146ESP-0046Case | SEX:Female | AGE_DICH:over50
SA044147ESP-0020Case | SEX:Female | AGE_DICH:over50
SA044148ESP-0306Case | SEX:Female | AGE_DICH:over50
SA044149ESP-0215Case | SEX:Female | AGE_DICH:over50
SA044150ESP-0423Case | SEX:Female | AGE_DICH:over50
SA044151ESP-1203Case | SEX:Male | AGE_DICH:20_50
SA044152ESP-1255Case | SEX:Male | AGE_DICH:over50
SA044153ESP-0826Case | SEX:Male | AGE_DICH:over50
SA044154ESP-0813Case | SEX:Male | AGE_DICH:over50
SA044155ESP-0072Case | SEX:Male | AGE_DICH:over50
SA044156ESP-0033Case | SEX:Male | AGE_DICH:over50
SA044157ESP-0644Case | SEX:Male | AGE_DICH:over50
SA044158ESP-0462Case | SEX:Male | AGE_DICH:over50
SA044159ESP-0904Case | SEX:Male | AGE_DICH:over50
SA044160ESP-0098Control | SEX:Female | AGE_DICH:20_50
SA044161ESP-0111Control | SEX:Female | AGE_DICH:20_50
SA044162ESP-0254Control | SEX:Female | AGE_DICH:20_50
SA044163ESP-0176Control | SEX:Female | AGE_DICH:20_50
SA044164ESP-0202Control | SEX:Female | AGE_DICH:20_50
SA044165ESP-0774Control | SEX:Female | AGE_DICH:20_50
SA044166ESP-0852Control | SEX:Female | AGE_DICH:20_50
SA044167ESP-0059Control | SEX:Female | AGE_DICH:20_50
SA044168ESP-1294Control | SEX:Female | AGE_DICH:20_50
SA044169ESP-1021Control | SEX:Female | AGE_DICH:20_50
SA044170ESP-0579Control | SEX:Female | AGE_DICH:20_50
SA044171ESP-0410Control | SEX:Female | AGE_DICH:20_50
SA044172ESP-0553Control | SEX:Female | AGE_DICH:20_50
SA044173ESP-1268Control | SEX:Female | AGE_DICH:20_50
SA044174ESP-0618Control | SEX:Female | AGE_DICH:20_50
SA044175ESP-1190Control | SEX:Female | AGE_DICH:20_50
SA044176ESP-0319Control | SEX:Female | AGE_DICH:20_50
SA044177ESP-1060Control | SEX:Female | AGE_DICH:over50
SA044178ESP-0436Control | SEX:Female | AGE_DICH:over50
SA044179ESP-1177Control | SEX:Female | AGE_DICH:over50
SA044180ESP-0449Control | SEX:Female | AGE_DICH:over50
SA044181ESP-1086Control | SEX:Female | AGE_DICH:over50
SA044182ESP-1112Control | SEX:Female | AGE_DICH:over50
SA044183ESP-0475Control | SEX:Female | AGE_DICH:over50
SA044184ESP-1099Control | SEX:Female | AGE_DICH:over50
SA044185ESP-1229Control | SEX:Female | AGE_DICH:over50
SA044186ESP-0917Control | SEX:Female | AGE_DICH:over50
SA044187ESP-0722Control | SEX:Female | AGE_DICH:over50
SA044188ESP-1008Control | SEX:Female | AGE_DICH:over50
SA044189ESP-0293Control | SEX:Female | AGE_DICH:over50
SA044190ESP-0527Control | SEX:Female | AGE_DICH:over50
SA044191ESP-0358Control | SEX:Female | AGE_DICH:over50
SA044192ESP-0371Control | SEX:Female | AGE_DICH:over50
SA044193ESP-0670Control | SEX:Female | AGE_DICH:over50
SA044194ESP-0267Control | SEX:Female | AGE_DICH:over50
SA044195ESP-0787Control | SEX:Female | AGE_DICH:over50
SA044196ESP-0397Control | SEX:Female | AGE_DICH:over50
SA044197ESP-0969Control | SEX:Female | AGE_DICH:over50
SA044198ESP-0930Control | SEX:Female | AGE_DICH:over50
SA044199ESP-0384Control | SEX:Female | AGE_DICH:over50
SA044200ESP-0839Control | SEX:Female | AGE_DICH:over50
SA044201ESP-1281Control | SEX:Male | AGE_DICH:20_50
SA044202ESP-1073Control | SEX:Male | AGE_DICH:20_50
SA044203ESP-1307Control | SEX:Male | AGE_DICH:20_50
SA044204ESP-0631Control | SEX:Male | AGE_DICH:over50
SA044205ESP-0735Control | SEX:Male | AGE_DICH:over50
SA044206ESP-0150Control | SEX:Male | AGE_DICH:over50
SA044207ESP-0163Control | SEX:Male | AGE_DICH:over50
SA044208ESP-0540Control | SEX:Male | AGE_DICH:over50
SA044209ESP-1216Control | SEX:Male | AGE_DICH:over50
Showing results 1 to 100 of 100

Collection:

Collection ID:CO000821
Collection Summary:Subjects included 50 cases and 50 controls from the Chronic Fatigue Initiative (CFI) Cohort (28) recruited at 4 sites across the US who met the 1994 CDC Fukuda and/or Canadian consensus criteria for ME/CFS.
Sample Type:Blood
Blood Serum Or Plasma:Plasma

Treatment:

Treatment ID:TR000841
Treatment Summary:Subjects included 50 cases and 50 controls from the Chronic Fatigue Initiative (CFI) Cohort (28) recruited at 4 sites across the US who met the 1994 CDC Fukuda and/or Canadian consensus criteria for ME/CFS.

Sample Preparation:

Sampleprep ID:SP000834
Sampleprep Summary:1.Thaw each 20 μL plasma aliquot at room temperature (see Aliquoting TEDDY samples SOP). Once thawed (~10min) place liquid plasma samples on ice. 2. Add 225 μL cold “MeOH with QC mix” (see SOP “QC mix for LC-MS lipid analysis”). Keep MeOH on ice during extraction 3. Vortex each sample for 10s, keeping the rest on ice during all the extraction. 4. Add 750 μL of cold MTBE with 22:1 CE, keep MTBE on ice during extraction 5. Vortex for 10s 6. Shake for 6min at 4°C in the orbital mixer. 7. Add 188 μL room temperature LC/MS grade water. 8. Vortex for 20 s 9. Centrifuge for 2 min @ 14,000 rcf (12300 rpm) 10. Remove supernatant, splitting into two aliquots of 350 μL, keeping one at –20°C for backup 11. Dry samples to complete dryness in the speed vacuum concentration system
Sampleprep Protocol Filename:SP_SOP_Extraction_of_plasma.pdf

Combined analysis:

Analysis ID AN001274
Analysis type MS
Chromatography type Reversed phase
Chromatography system Waters Acquity
Column Waters Acquity BEH C18 (150 x 2.1mm,1.7um)
MS Type ESI
MS instrument type Triple quadrupole
MS instrument name ABI Sciex API 4000 QTrap
Ion Mode NEGATIVE
Units Concentration (nM)

Chromatography:

Chromatography ID:CH000890
Instrument Name:Waters Acquity
Column Name:Waters Acquity BEH C18 (150 x 2.1mm,1.7um)
Column Temperature:60 °C
Flow Gradient:0 min 25% (B), 1 min 40% (B), 1-2.5 min 42% (B), 2.5-4.5 50% (B), 4.5-10.5 65% (B), 10.5-12.5 75% (B), 12.5-14 85% (B), 14-14.5 95% (B), 14.5-15 25% (B), 15-16 25% (B)
Flow Rate:0.25 uL
Sample Injection:5 µL
Solvent A:100% water; 0.1% acetic acid
Solvent B:90% acetonitrile/ 10% isopropanol
Analytical Time:16 min
Washing Buffer:Ethyl Acetate
Weak Wash Solvent Name:20% methanol, 10% isopropanol
Weak Wash Volume:600 µL
Strong Wash Solvent Name:50:50 Acetonitrile:Methanol
Strong Wash Volume:600 µL
Sample Loop Size:17 µL
Randomization Order:Excel generated
Chromatography Type:Reversed phase

MS:

MS ID:MS001167
Analysis ID:AN001274
Instrument Name:ABI Sciex API 4000 QTrap
Instrument Type:Triple quadrupole
MS Type:ESI
Ion Mode:NEGATIVE
  logo